Yasuhiro Maeda Selected Research

3- (4- (4- chlorophenyl- 4- hydroxypiperidino)methyl)indole

1/2018

The anti-influenza drug oseltamivir evokes hypothermia in mice through dopamine D2 receptor activation via central actions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Maeda Research Topics

Disease

16	Neoplasms (Cancer) 04/2024 - 05/2005
11	Erectile Dysfunction 10/2022 - 03/2011
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2019 - 05/2005
9	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2015 - 01/2007
7	Philadelphia Chromosome 04/2024 - 05/2005
7	Multiple Sclerosis 12/2020 - 05/2002
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 03/2009
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2018 - 07/2003
4	Inflammation (Inflammations) 01/2021 - 05/2014
4	Hypertension (High Blood Pressure) 01/2020 - 09/2009
4	Fibrosis (Cirrhosis) 01/2020 - 01/2003
4	Autoimmune Diseases (Autoimmune Disease) 07/2017 - 02/2006
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2022 - 12/2020
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2020 - 07/2017
3	Hypothermia 01/2018 - 07/2013
3	Human Influenza (Influenza) 01/2018 - 10/2012
3	Infections 01/2018 - 01/2007
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015 - 12/2004
3	Type 2 Diabetes Mellitus (MODY) 04/2014 - 04/2009
3	Lymphoma (Lymphomas) 05/2012 - 02/2009
3	Peritoneal Fibrosis 01/2008 - 01/2003
2	Diabetes Mellitus 09/2022 - 09/2009
2	Disease Progression 01/2022 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2019
2	Autonomic Nervous System Diseases (Dysautonomia) 11/2021 - 01/2021
2	Myasthenia Gravis 04/2021 - 05/2020
2	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 07/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 05/2014
2	Bradycardia 01/2017 - 09/2015
2	Optic Neuritis (Retrobulbar Neuritis) 01/2016 - 04/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014 - 03/2010
2	Leukemia 01/2014 - 10/2008
2	T-Cell Leukemia (Leukemia, T Cell) 04/2013 - 06/2008
2	Hemorrhage 12/2010 - 03/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2010 - 02/2009
2	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2009 - 07/2008

Drug/Important Bio-Agent (IBA)

16	AntibodiesIBA 09/2022 - 10/2002
9	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 05/2005
7	AutoantibodiesIBA 12/2020 - 02/2009
5	Tyrosine Kinase InhibitorsIBA 04/2024 - 04/2012
5	Tryptophan (L-Tryptophan)FDA Link 03/2021 - 06/2015
5	Oseltamivir (Tamiflu)FDA Link 01/2018 - 10/2012
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016 - 07/2013
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2017
4	Rituximab (Mabthera)FDA Link 02/2022 - 01/2010
4	Cholinergic ReceptorsIBA 11/2021 - 01/2016
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017 - 02/2006
4	Erythropoietin FDA Link 04/2016 - 10/2002
4	Messenger RNA (mRNA)IBA 10/2009 - 05/2002
4	AdiponectinIBA 09/2009 - 02/2009
3	SaltsIBA 01/2020 - 11/2017
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2017
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019 - 01/2017
3	amiselimodIBA 01/2019 - 01/2017
3	Azacitidine (5 Azacytidine)FDA Link 10/2018 - 01/2014
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2016 - 12/2004
3	nilotinib FDA Link 04/2012 - 06/2009
3	Sirolimus (Rapamycin)FDA Link 10/2009 - 07/2003
3	RV 538 (PDMP)IBA 09/2009 - 02/2009
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2008 - 03/2007
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2008 - 01/2003
2	Testosterone (Sustanon)FDA Link 10/2022 - 12/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022 - 01/2021
2	PlatinumIBA 04/2022 - 10/2008
2	Bendamustine Hydrochloride FDA Link 02/2022 - 08/2021
2	EnzymesIBA 03/2021 - 09/2020
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 03/2021 - 01/2018
2	NADP (NADPH)IBA 01/2021 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2018
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 01/2020
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2020 - 01/2019
2	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 03/2011
2	CreatinineIBA 01/2020 - 09/2009
2	Arginine (L-Arginine)FDA Link 01/2020 - 01/2019
2	Immunoglobulin G (IgG)IBA 06/2019 - 10/2016
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 01/2017
2	Therapeutic UsesIBA 01/2019 - 08/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 10/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2010
2	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2017 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017 - 04/2014
2	Immunoglobulin M (IgM)IBA 05/2017 - 01/2007
2	Peptides (Polypeptides)IBA 10/2016 - 04/2016
2	EpitopesIBA 10/2016 - 04/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 05/2002
2	SteroidsIBA 04/2015 - 12/2010
2	Neuraminidase (Sialidase)IBA 02/2015 - 07/2013
2	CitrullineIBA 06/2014 - 10/2013
2	CytokinesIBA 05/2014 - 01/2007
2	Vardenafil Dihydrochloride (Levitra)FDA Link 07/2012 - 03/2011
2	Carnitine (L-Carnitine)FDA LinkGeneric 08/2010 - 12/2007
2	ChemokinesIBA 09/2009 - 09/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2009 - 02/2009
2	Eicosapentaenoic AcidIBA 04/2009 - 02/2009

Therapy/Procedure

25	Therapeutics 04/2024 - 01/2004
6	Drug Therapy (Chemotherapy) 04/2024 - 05/2005
5	Immunotherapy 03/2021 - 01/2008
2	Hematopoietic Stem Cell Transplantation 04/2013 - 10/2010
2	Remission Induction 03/2010 - 03/2007
2	Renal Dialysis (Hemodialysis) 01/2010 - 10/2002